Apollo Hospitals Enterprise Limited

NSEI:APOLLOHOSP Stock Report

Market Cap: ₹969.8b

Apollo Hospitals Enterprise Future Growth

Future criteria checks 5/6

Apollo Hospitals Enterprise is forecast to grow earnings and revenue by 29.9% and 15.9% per annum respectively. EPS is expected to grow by 29.6% per annum. Return on equity is forecast to be 21.5% in 3 years.

Key information

29.9%

Earnings growth rate

29.6%

EPS growth rate

Healthcare earnings growth27.4%
Revenue growth rate15.9%
Future return on equity21.5%
Analyst coverage

Good

Last updated22 Jan 2025

Recent future growth updates

Here's What Analysts Are Forecasting For Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) After Its Second-Quarter Results

Nov 09
Here's What Analysts Are Forecasting For Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) After Its Second-Quarter Results

The Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Aug 16
The Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Analysts Are Updating Their Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Estimates After Its Third-Quarter Results

Feb 11
Analysts Are Updating Their Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Estimates After Its Third-Quarter Results

Recent updates

Apollo Hospitals Enterprise Limited's (NSE:APOLLOHOSP) Business Is Yet to Catch Up With Its Share Price

Dec 31
Apollo Hospitals Enterprise Limited's (NSE:APOLLOHOSP) Business Is Yet to Catch Up With Its Share Price

Is Apollo Hospitals Enterprise (NSE:APOLLOHOSP) A Risky Investment?

Dec 10
Is Apollo Hospitals Enterprise (NSE:APOLLOHOSP) A Risky Investment?

Here's What Analysts Are Forecasting For Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) After Its Second-Quarter Results

Nov 09
Here's What Analysts Are Forecasting For Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) After Its Second-Quarter Results

Why We Think Apollo Hospitals Enterprise Limited's (NSE:APOLLOHOSP) CEO Compensation Is Not Excessive At All

Aug 24
Why We Think Apollo Hospitals Enterprise Limited's (NSE:APOLLOHOSP) CEO Compensation Is Not Excessive At All

The Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Aug 16
The Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Apollo Hospitals Enterprise's (NSE:APOLLOHOSP) Upcoming Dividend Will Be Larger Than Last Year's

Aug 06
Apollo Hospitals Enterprise's (NSE:APOLLOHOSP) Upcoming Dividend Will Be Larger Than Last Year's

Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Is Increasing Its Dividend To ₹10.00

Jul 23
Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Is Increasing Its Dividend To ₹10.00

Apollo Hospitals Enterprise's (NSE:APOLLOHOSP) Returns On Capital Are Heading Higher

Apr 08
Apollo Hospitals Enterprise's (NSE:APOLLOHOSP) Returns On Capital Are Heading Higher

These 4 Measures Indicate That Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Is Using Debt Reasonably Well

Mar 18
These 4 Measures Indicate That Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Is Using Debt Reasonably Well

Analysts Are Updating Their Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Estimates After Its Third-Quarter Results

Feb 11
Analysts Are Updating Their Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Estimates After Its Third-Quarter Results

Earnings and Revenue Growth Forecasts

NSEI:APOLLOHOSP - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2027303,29125,18522,88834,95923
3/31/2026258,05619,52316,94429,13028
3/31/2025220,88714,42013,25122,11727
9/30/2024204,69411,8765,09616,464N/A
6/30/2024197,27010,372N/AN/AN/A
3/31/2024190,5928,9867,83419,202N/A
12/31/2023184,1757,893N/AN/AN/A
9/30/2023178,3056,9752,15113,436N/A
6/30/2023172,3476,685N/AN/AN/A
3/31/2023166,1258,1912,48413,769N/A
12/31/2022158,5667,647N/AN/AN/A
9/30/2022152,3208,39614,81321,385N/A
6/30/2022146,9808,834N/AN/AN/A
3/31/2022146,62610,55610,38816,960N/A
12/31/2021139,84111,334N/AN/AN/A
9/30/2021131,05110,35411,96314,918N/A
6/30/2021121,4878,479N/AN/AN/A
3/31/2021105,6001,5049,69212,647N/A
12/31/2020106,1452,018N/AN/AN/A
9/30/2020107,6641,6356,81611,946N/A
6/30/2020108,4641,895N/AN/AN/A
3/31/2020112,4684,5497,79912,929N/A
12/31/2019108,2393,172N/AN/AN/A
9/30/2019104,0722,8211,8128,601N/A
6/30/201999,7892,593N/AN/AN/A
3/31/201996,1752,3602,2639,052N/A
3/31/201882,4351,174N/A5,370N/A
3/31/201772,5572,210N/A6,226N/A
3/31/201662,1472,364N/A5,972N/A
3/31/201551,7853,399N/A4,699N/A
3/31/201443,8423,167N/A3,734N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: APOLLOHOSP's forecast earnings growth (29.9% per year) is above the savings rate (6.7%).

Earnings vs Market: APOLLOHOSP's earnings (29.9% per year) are forecast to grow faster than the Indian market (17.9% per year).

High Growth Earnings: APOLLOHOSP's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: APOLLOHOSP's revenue (15.9% per year) is forecast to grow faster than the Indian market (10.9% per year).

High Growth Revenue: APOLLOHOSP's revenue (15.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: APOLLOHOSP's Return on Equity is forecast to be high in 3 years time (21.5%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/25 22:24
End of Day Share Price 2025/01/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Apollo Hospitals Enterprise Limited is covered by 59 analysts. 28 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Prashant NairAmbit Capital
Nitin BhasinAmbit Capital
Sriraam RathiAnand Rathi Shares and Stock Brokers Limited